Purpose: The purpose of the Global Patient Safety Pharmacoepidemiologist (GPS PE), reporting into GPS Medical, is to provide scientific and data driven guidance to meet strategic objectives in the generation of data to characterize the safety profile of Lilly products. The GPS PE contributes to cross-functional teams that are responsible for generation of primary data or analysis of secondary data sources to contribute to the assessment of the benefit-risk profile of Lilly products. The GPS PE is responsible for supporting the development and execution of risk management plans; identifying and evaluating potential safety signals, addressing safety questions from regulators, and designing and conducting pharmacoepidemiology studies. The GPS PE role may also entail some in-line or project-level supervisory responsibilities. Primary Responsibilities: This job description is intended to provide a general overview of the job requirements at the time it was prepared. The job requirements of any position may change over time and may include additional responsibilities not specifically described in the job description. Not all listed responsibilities will be applicable to all GPS PE roles. Consult with your supervisor regarding your actual job responsibilities and any related duties that may be required for the position. Study Design & Execution -Collaborates within a cross-functional team and leads the design and execution of observational studies to ensure high quality, scientifically rigorous pharmacoepidemiology study proposals, protocols, statistical analysis plans, clinical study reports, abstracts/publications and/or presentations. -Contribute to the Risk Management Strategy/Real World Evidence Safety Strategy for assigned molecule(s). -Design, coordination, and implementation of observational epidemiological studies (including secondary use dataset studies) on epidemiology disease burden, natural history of disease, and assessment of background rates for identified/potential drug risks. -Develop new methodologies and appropriately utilize pharmacoepidemiologic tools for the identification and analysis of potential safety signals; apply in-depth epidemiologic methods to address complex research questions. -Lead the conduct of the pharmacoepidemiology studies internally (when appropriate) and collaborate/contract with external investigators and Third-Party Organizations as needed; provide scientific expertise in interpretation and communication of results of pharmacoepidemiology studies. -Collaborate on developing strategic analytic tools to support activities such as disease state characterization, signal detection, clarification, and evaluation utilizing multiple data sources (e.g., spontaneous, health claims and electronic health records); partner on the development of new standardized analytic methods for selected regulatory safety documents/submissions (e.g., PBRER/PSUR, ISS, product labels). Regulatory Support and Public Health Impact -Provides input into regulatory documents such as Risk Management Plans, Periodic Benefit-Risk Evaluation Reports, and responses to regulatory queries. -Provide epidemiological expertise as it relates to signal detection and signal management for the portfolio. -Collect and analyze patient population data from literature/other sources to assess disease burden providing support for regulatory submissions (e.g., Orphan Drug Applications, Pediatric Investigation Plans, or Pediatric Study Plans). -Represent Lilly and coordinate its presence in external epidemiology or drug safety groups. -Stay updated on regulatory activities (eg, FDA, EMA) related to epidemiology. -Use external contacts for scientific intelligence through benchmarking projects and forums. Data Source Expertise -Deep understanding of RWD and methodology including digital tools. -Demonstrate knowledge of relevant global regulatory requirements and practices; act as subject matter expert in the development and maintenance of procedures and required tools in the quality system as they relate to epidemiology. -Develop analytic tools to support activities such as disease state characterization, signal detection, clarification, and evaluation utilizing multiple data sources (e.g., spontaneous, health claims and electronic health records); partner on the development of new standardized analytic methods for selected regulatory safety documents/submissions (e.g., PBRER/PSUR, ISS, product labels). Lifecycle Management -Support strategy across lifecycle through evidence generation. -Contribute to the Risk Management Strategy/RWE Safety Strategy for a molecule. -Design/execution/interpretation of pharmacoepidemiology studies including design and review of study protocols, SAPs, final study reports, presentations, and manuscripts. -Lead the conduct of the pharmacoepidemiology studies internally (when appropriate) and collaborate/contract with external investigators and CROs as needed; provide scientific expertise in interpretation and communication of results of pharmacoepidemiology studies. Training, Coaching, Mentoring -Provide training, coaching and mentorship demonstrating effective PV strategies and sharing experience and knowledge to further advance the goals of the GPS department and wider enterprise. -Maintain compliance with Lilly Red Book and corporate policies, Lilly Research Laboratories and Global Patient Safety curriculum. -Maintaining compliance with the Lilly Corporate Integrity Agreement. People Management -Foster and support a collaborative working environment that maintains a Team Lilly culture focused on inclusion, innovation, acceleration, and delivery. -Recruit, mentor, develop, and retain top scientific and drug development talent. -Assure staff comply with company policies and procedures. Understand and support the QPPV role -Understanding the roles and responsibilities of the European Union Qualified Person (QPPV). -Ensure support is provided to enable the Qualified Person to fulfill all the Qualified Person legal responsibilities. Minimum Qualification Requirements: PhD in Epidemiology or related Public Health field) and 3+ years of experience in scientific research or the pharmaceutical industry. Other Information/Additional Preferences -High-level knowledge of global regulations with respect to drug safety and adverse event reporting -Strong analytical skills and ability to apply statistical and epidemiological methodology in research projects as well as understanding of risk management strategies and risk minimization programs. -Competent in the conduct of epidemiology studies; competency in the independent analysis of data and interpretation of results from clinical and epidemiology studies. Excellent computer skills; knowledge of statistical software packages to analyze epidemiological data. -Highly effective written and verbal communication skills. -Ability to work on multiple projects and function effectively in a fast-paced matrixed environment. -Ability to prioritize tasks and shift priorities rapidly to meet tight deadlines. -Ability to influence others (both cross-functionally and within the function) in order to create a positive working environment. -Excellent teamwork skills -Applying AI-driven programming techniques to enhance pharmacoepidemiologic study design, data analysis, and signal detection activities -Ability to learn and apply technical knowledge to meet changing project needs. -Experience using longitudinal national databases, claims databases, or electronic medical records (e.g. GPRD) for epidemiologic research -Strategic thinker with proven project execution and innovation experience. Actual compensation will depend on a candidate's education, experience, skills, and geographic location. The anticipated wage for this position is $171,000 - $299,200 Full-time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance). In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company-sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities).Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly's compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees.